New advances in the clinical management of RAS and BRAF mutant colorectal cancer patients.

作者: Jose Carlos Ruffinelli , Cristina Santos Vivas , Rebeca Sanz-Pamplona , Victor Moreno

DOI: 10.1080/17474124.2021.1826305

关键词: MedicineMutantColorectal cancerTargeted therapyColorectal carcinogenesisMAPK/ERK pathwayCancer researchCancer

摘要: In colorectal carcinogenesis, genetic alterations in RAS and BRAF oncogenes play an important role for cancer initiation and/or progression represent a key focus the search targeted ther...

参考文章(137)
Scott Kopetz, Van Morris, Clinical biomarkers in colorectal cancer. Clinical advances in hematology & oncology. ,vol. 11, pp. 768- ,(2013)
T Macarulla, A Cervantes, J Tabernero, S Roselló, E Van Cutsem, S Tejpar, H Prenen, E Martinelli, T Troiani, B Laffranchi, V Jego, O von Richter, F Ciardiello, Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS -mutated metastatic colorectal cancer British Journal of Cancer. ,vol. 112, pp. 1874- 1881 ,(2015) , 10.1038/BJC.2015.144
Enric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif, Daniel Rosmarin, Michal Presz, Haitao Wang, Hannah Pulker, Helen Lockstone, Tarjei Hveem, Treena Cranston, Havard Danielsen, Marco Novelli, Brian Davidson, Zheng‐Zhou Xu, Peter Molloy, Elaine Johnstone, Christopher Holmes, Rachel Midgley, David Kerr, Oliver Sieber, Ian Tomlinson, Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. The Journal of Pathology. ,vol. 229, pp. 441- 448 ,(2013) , 10.1002/PATH.4139
Andrew Rowland, Mafalda M Dias, Michael D Wiese, Ganessan Kichenadasse, Ross A McKinnon, Christos S Karapetis, Michael J Sorich, Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer. British Journal of Cancer. ,vol. 112, pp. 1888- 1894 ,(2015) , 10.1038/BJC.2015.325
David M. Hyman, Igor Puzanov, Vivek Subbiah, Jason E. Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S. Raje, Eli L. Diamond, Antoine Hollebecque, Radj Gervais, Maria Elena Elez-Fernandez, Antoine Italiano, Ralf-Dieter Hofheinz, Manuel Hidalgo, Emily Chan, Martin Schuler, Susan Frances Lasserre, Martina Makrutzki, Florin Sirzen, Maria Luisa Veronese, Josep Tabernero, José Baselga, Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations The New England Journal of Medicine. ,vol. 373, pp. 726- 736 ,(2015) , 10.1056/NEJMOA1502309
C. Cremolini, M. Di Bartolomeo, A. Amatu, C. Antoniotti, R. Moretto, R. Berenato, F. Perrone, E. Tamborini, G. Aprile, S. Lonardi, A. Sartore-Bianchi, G. Fontanini, M. Milione, C. Lauricella, S. Siena, A. Falcone, F. de Braud, F. Loupakis, F. Pietrantonio, BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis Annals of Oncology. ,vol. 26, pp. 2092- 2097 ,(2015) , 10.1093/ANNONC/MDV290
Ryan B. Corcoran, Chloe E. Atreya, Gerald S. Falchook, Eunice L. Kwak, David P. Ryan, Johanna C. Bendell, Omid Hamid, Wells A. Messersmith, Adil Daud, Razelle Kurzrock, Mariaelena Pierobon, Peng Sun, Elizabeth Cunningham, Shonda Little, Keith Orford, Monica Motwani, Yuchen Bai, Kiran Patel, Alan P. Venook, Scott Kopetz, Combined BRAF and MEK inhibition with dabrafenib and trametinib in BRAF V600-Mutant colorectal cancer Journal of Clinical Oncology. ,vol. 33, pp. 4023- 4031 ,(2015) , 10.1200/JCO.2015.63.2471
Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien De Reynies, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino, Brian M Bot, Jeffrey S Morris, Iris M Simon, Sarah Gerster, Evelyn Fessler, Felipe De Sousa E Melo, Edoardo Missiaglia, Hena Ramay, David Barras, Krisztian Homicsko, Dipen Maru, Ganiraju C Manyam, Bradley Broom, Valerie Boige, Beatriz Perez-Villamil, Ted Laderas, Ramon Salazar, Joe W Gray, Douglas Hanahan, Josep Tabernero, Rene Bernards, Stephen H Friend, Pierre Laurent-Puig, Jan Paul Medema, Anguraj Sadanandam, Lodewyk Wessels, Mauro Delorenzi, Scott Kopetz, Louis Vermeulen, Sabine Tejpar, None, The consensus molecular subtypes of colorectal cancer Nature Medicine. ,vol. 21, pp. 1350- 1356 ,(2015) , 10.1038/NM.3967
Feriyl Bhaijee, Thomas Huebner, Ralph H. Hruban, Laura D. Wood, Nathan Cuka, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Toby C. Cornish, Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Diaz, Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra D. Eyring, Andrew D. Skora, Brandon S. Luber, Nilofer S. Azad, Dan Laheru, Barbara Biedrzycki, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Steven M. Duffy, Richard M. Goldberg, Albert de la Chapelle, Minori Koshiji, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency The New England Journal of Medicine. ,vol. 372, pp. 2509- 2520 ,(2015) , 10.1056/NEJMOA1500596
Markus Morkel, Pamela Riemer, Hendrik Bläker, Christine Sers, Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance Oncotarget. ,vol. 6, pp. 20785- 20800 ,(2015) , 10.18632/ONCOTARGET.4750